Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis
Benjamin Meyer(University of Geneva), Christiane S. Eberhardt(University of Geneva), Paola Martinez-Murillo(University of Geneva), Barbara Lemaître, Chantal Tougne(University of Geneva), Julie Sartoretti(University of Geneva), Claire‐Anne Siegrist(University of Geneva), Natasha Loevy(University of Geneva), Laurent Kaiser(University Hospital of Geneva), Angela Huttner(University Hospital of Geneva), Géraldine Blanchard‐Rohner(University of Geneva), Paola Fontannaz(University of Geneva), Jean Villard(University Hospital of Geneva), Arnaud M. Didierlaurent(University of Geneva), Paul‐Henri Lambert(University of Geneva), Chloé Eugercios Manzanas(University of Geneva)
Cited by 2
Related Papers
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
|The Journal of Immunology|2009|739
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
|New England Journal of Medicine|2015|412
Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection
|The Journal of Experimental Medicine|2008|390